Guideline recommendations for the treatment of early-stage glottic cancer are limited to single-modality therapy with surgery or radiation alone. We sought to investigate the clinicopathologic and treatment factors associated with the use of postoperative radiation therapy (PORT) following laser excision for patients with T1-T2N0 glottic squamous cell carcinoma (SCC).
Study Design
Retrospective observational study of the National Cancer Database.
Setting
National Cancer Database review from 2004 to 2014.
Patients and Methods
A total of 1338 patients with primary cT1-T2N0M0 glottic SCC undergoing primary laser excision were included. Hospitals were divided into quartiles based on yearly volume of laryngeal laser cases performed. Multivariate logistic regression was performed to identify independent predictors of PORT.
Results
The overall rate of PORT was 30.0%. Predictors of PORT included treatment at lower-volume hospitals (adjusted odds ratio [aOR] for quartiles 2-4, 1.32-4.84), positive margins (aOR, 3.83 [95% CI, 2.54-5.78]), and T2 tumors (aOR, 3.58 [95% CI, 2.24-5.74]). PORT utilization demonstrated a strong inverse correlation with hospital volume. Among top-quartile hospitals, the rate of PORT was 11.2%, while rates of PORT at second-, third-, and fourth-quartile institutions were 19.2%, 32.2%, and 37.4%, respectively.
Conclusions
Predictors of PORT in multivariable analysis included treatment at lower-volume facilities, positive margins, and T2 disease. This study highlights the importance of treating early-stage glottic carcinoma at high-volume institutions. In addition, there is a need to reevaluate the use of PORT and reduce the rate of dual-modality therapy for patients with early-stage glottic SCC.
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): head and neck cancers. National Comprehensive Cancer Network; 2018.
2.
ForastiereAAIsmailaNLewinJS, et al. Use of larynx-preservation strategies in the treatment of laryngeal cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2018;36(11):1143-1169.
3.
GardenASForsterKWongPFMorrisonWHSchechterNRAngKK.Results of radiotherapy for T2N0 glottic carcinoma: does the “2” stand for twice-daily treatment?Int J Radiat Oncol Biol Phys. 2003;55(2):322-328.
4.
YamazakiHNishiyamaKTanakaEKoizumiMChataniM.Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys. 2006;64(1):77-82.
5.
YamazakiHSuzukiGNakamuraS, et al. Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation. J Radiat Res. 2017;58(4):495-508.
6.
GrantDGRepanosCMalpasGSalassaJRHinniML.Transoral laser microsurgery for early laryngeal cancer. Expert Rev Anticancer Ther. 2010;10(3):331-338.
7.
LeeHSChunBGKimSW, et al. Transoral laser microsurgery for early glottic cancer as one-stage single-modality therapy. Laryngoscope. 2013;123(11):2670-2674.
8.
PradhanSAPaiPSNeeliSID’CruzAK.Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg. 2003;129(6):623-625.
9.
RemmeltsAJHoebersFJKlopWMBalmAJHamming-VriezeOvan den BrekelMW.Evaluation of lasersurgery and radiotherapy as treatment modalities in early stage laryngeal carcinoma: tumour outcome and quality of voice. Eur Arch Otorhinolaryngol. 2013;270(7):2079-2087.
10.
AnschuetzLShelanMDematteMSchubertADGigerRElicinO.Long-term functional outcome after laryngeal cancer treatment. Radiat Oncol. 2019;14(1):101.
11.
MendenhallWMAmdurRJMorrisCGHinermanRW.T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol. 2001;19(20):4029-4036.
12.
SiddiquiFMovsasB.Management of radiation toxicity in head and neck cancers. Semin Radiat Oncol. 2017;27(4):340-349.
13.
WilliamsonJSIngramsDJonesH.Quality of life after treatment of laryngeal carcinoma: a single centre cross-sectional study. Ann R Coll Surg Engl. 2011;93(8):591-595.
14.
BilimoriaKYStewartAKWinchesterDPKoCY.The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683-690.
15.
DeyoRACherkinDCCiolMA.Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
16.
AbdurehimYHuaZYasinYXukurhanAImamIYuqinF.Transoral laser surgery versus radiotherapy: systematic review and meta-analysis for treatment options of T1a glottic cancer. Head Neck. 2012;34(1):23-33.
17.
HendriksmaMHeijnenBJSjogrenEV.Oncologic and functional outcomes of patients treated with transoral CO2 laser microsurgery or radiotherapy for T2 glottic carcinoma: a systematic review of the literature. Curr Opin Otolaryngol Head Neck Surg. 2018;26(2):84-93.
18.
MendenhallWMWerningJWHinermanRWAmdurRJVillaretDB.Management of T1-T2 glottic carcinomas. Cancer. 2004;100(9):1786-1792.
19.
YooJLacchettiCHammondJAGilbertRW.Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: a systematic review. Head Neck. 2014;36(12):1807-1819.
20.
SchrijversMLvan RielELLangendijkJA, et al. Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma. Head Neck. 2009;31(6):759-764.
21.
HigginsKM.What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility?Laryngoscope. 2011;121(1):116-134.
22.
CanisMIhlerFMartinAMatthiasCSteinerW.Transoral laser microsurgery for T1a glottic cancer: review of 404 cases. Head Neck. 2015;37(6):889-895.
23.
FangTJCoureyMSLiaoCTYenTCLiHY.Frozen margin analysis as a prognosis predictor in early glottic cancer by laser cordectomy. Laryngoscope. 2013;123(6):1490-1495.
24.
CanisMMartinAIhlerF, et al. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma—results of 391 patients. Head Neck. 2014;36(6):859-866.
25.
FizIKoelmelJCSittelC.Nature and role of surgical margins in transoral laser microsurgery for early and intermediate glottic cancer. Curr Opin Otolaryngol Head Neck Surg. 2018;26(2):78-83.
26.
FurusakaTMatsudaASaitoTKatsuraYIkedaM.Concurrent chemoradiation therapy with docetaxel (DOC) for laryngeal preservation in T2N0M0 glottic squamous cell carcinomas. Acta Otolaryngol. 2013;133(1):99-112.
27.
FurusakaTSusakiYSaitoTKatsuraYIkedaM.Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation. Acta Otolaryngol. 2013;133(1):91-98.
28.
AkimotoTNonakaTKitamotoY, et al. Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys. 2006;64(4):995-1001.
29.
WolfGTBellileEEisbruchA, et al. Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2017;143(4):355-366.
30.
HakeemAHTubachiJPradhanSA.Significance of anterior commissure involvement in early glottic squamous cell carcinoma treated with trans-oral CO2 laser microsurgery. Laryngoscope. 2013;123(8):1912-1917.
31.
TulliMReMBondiS, et al. The prognostic value of anterior commissure involvement in T1 glottic cancer: a systematic review and meta-analysis. Laryngoscope. Published online November13, 2019. doi:10.1002/lary.28395
32.
ChenAYFedewaSPavluckAWardEM.Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer. 2010;116(20):4744-4752.
33.
ChenAYPavluckAHalpernMWardE.Impact of treating facilities’ volume on survival for early-stage laryngeal cancer. Head Neck. 2009;31(9):1137-1143.
34.
CheraghlouSKuoPJudsonBL.Treatment delay and facility case volume are associated with survival in early-stage glottic cancer. Laryngoscope. 2017;127(3):616-622.
35.
EskanderAMonteiroEIrishJ, et al. Adherence to guideline-recommended process measures for squamous cell carcinoma of the head and neck in Ontario: impact of surgeon and hospital volume. Head Neck. 2016;38(suppl 1):E1987-E1992.
36.
GourinCGForastiereAASanguinetiGKochWMMarurSBristowRE.Impact of surgeon and hospital volume on short-term outcomes and cost of laryngeal cancer surgical care. Laryngoscope. 2011;121(1):85-90.
37.
GourinCGFrickKD.National trends in laryngeal cancer surgery and the effect of surgeon and hospital volume on short-term outcomes and cost of care. Laryngoscope. 2012;122(1):88-94.
38.
NoconCCAjmaniGSBhayaniMK.Association of facility volume with positive margin rate in the surgical treatment of head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2018;144(12):1090-1097.
39.
LuryiALChenMMMehraSRomanSASosaJAJudsonBL.Positive surgical margins in early stage oral cavity cancer: an analysis of 20,602 cases. Otolaryngol Head Neck Surg. 2014;151(6):984-990.
40.
GraboyesEMGarrett-MayerEEllisMA, et al. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017;123(24):4841-4850.
41.
GraboyesEMGarrett-MayerESharmaAKLentschEJDayTA.Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017;123(14):2651-2660.
42.
FizIMazzolaFFizF, et al. Impact of close and positive margins in transoral laser microsurgery for Tis-T2 glottic cancer. Front Oncol. 2017;7:245.
43.
PerettiGPiazzaCCoccoD, et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck. 2010;32(8):977-983.
44.
WeissBGIhlerFPilavakisY, et al. Transoral laser microsurgery for T1b glottic cancer: review of 51 cases. Eur Arch Otorhinolaryngol. 2017;274(4):1997-2004.
45.
PreussSFCramerKDrebberUKlussmannJPEckelHEGuntinas-LichiusO.Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer. Acta Otolaryngol. 2009;129(8):881-885.
46.
JumailyMFarajiFOsazuwa-PetersNWalkerRJWardGM.Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma. Oral Oncol. 2019;97:105-111.
